Period of time: 2014年2期
Publisher: Informa Healthcare
Founded in: 1996
Total resources: 42
ISSN: 1472-8214
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Emerging Drugs,volume 12,issue 2
Menu
Future pharmacotherapy in chronic bladder hypersensory conditions
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.A novel perspective on natural therapeutic approaches in glaucoma therapy
By Mozaffarieh Maneli,Flammer Josef in (2007)
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.Emerging drugs for hepatitis B
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.The future of the oral pharmacotherapy of male erectile dysfunction: things to come
By Ückert Stefan,Mayer Margit E,Stief Christian G,Jonas Udo in (2007)
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.By Bedlack Richard S,Traynor Bryan J,Cudkowicz Merit E in (2007)
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.Emerging therapies for the treatment of patients with advanced neuroendocrine tumors
By Chan Jennifer A,Kulke Matthew H in (2007)
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.Ras as a therapeutic target in hematologic malignancies
By Alvarado Yesid,Giles Francis J in (2007)
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.Luteinising hormone-releasing hormone antagonists in prostate cancer therapy
By Msaouel Pavlos,Diamanti Evanthia,Tzanela Marinela,Koutsilieris Michael in (2007)
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.Emerging drugs for the treatment of pancreatic cancer
By Van Laethem Jean-Luc,Marechal Raphael in (2007)
Expert Opinion on Emerging Drugs,volume 12,issue 2 , Vol. 12, Iss. 2, 2007-05 , pp.